GSK Offers $28M To Settle Suits Over Defective Paxil

Law360, New York (March 2, 2009, 12:00 AM EST) -- GlaxoSmithKline PLC has agreed to pay $28 million to settle two proposed class actions over claims that the company's Puerto Rico plant produced defective versions of the company's antidepressant Paxil CR that caused the pills to split apart into their active ingredient and controlled release halves.

Judge Gustavo Gelpi of the U.S. District Court for the District of Puerto Rico gave the proposed settlement and request for class certification preliminary approval Monday, with a fairness hearing set for July.

The arrangement would provide up to $11.2...
To view the full article, register now.